The New Method 

Break up a tablet of Ergotamine in such a way that a piece of half a milligram is left over. Crumble this piece of the tablet up and fill it into a tuberculin syringe after having removed the seal. One should, however, first remove the cone of the cannula using a bread knife with a sharp serrated blade and then smooth away the cut surface. After reinserting the seal into the syringe, the crumbled bits of the tablet are pulled up with 1 ml of tap water and soaked up by turning the syringe (1 minute). The syringe with the prepared medication is then inserted 7 cm deep directly into the anus (do not use force, use Vaseline) with the blunt plunger of the syringe (so without needle ! !) after which the medication is inserted, just like with a suppository. The efficacy of the freshly prepared watery medication is much higher with a low dosage (½ mg) than the efficacy of the suppositories of 2 mg. 

You should apply this treatment at the onset of definite signs of a migraine attack; when applied too late during an attack it sometimes takes more than 1 mg and about 1 hour before the symptoms subside. Dissolving the tablet and injecting the solution can be done inconspicuously on any toilet and does not take longer than three minutes.

Nowadays, when physicians write a prescription for Ergotamine for migraine patients, which is seldom the case, the prescription is usually for Ergotamine tablets meant for administration via the mouth and the stomach. It is known, however, that this method of treatment is neither very effective nor reliable. This in turn unjustly brings many physicians and patients to the conclusion that Ergotamine is an ineffective medication. In reality it is only ineffective when administered incorrectly or by means of a wrong carrier. The release of Ergotamine in suppositories is also not very effective. In the past, patients often used 6 mg or more of Ergotamine per day. The high quantities of Ergotamine and the frequent application of Ergotamine in combination with additional pain killers used to be the cause of severe adverse effects. 

According to specialist information, the maximum monthly dosage of Ergotamine which is considered safe is 6 mg per day, 10 mg per week and 20 mg per month. Using my method, 3 mg of Ergotamine is a sufficient dosage per month in order to suppress up to 6 migraine attacks effectively.

I did not experience any significant acute or permanent adverse effects using this method; additional pain killers or medication against nausea were also not required since the nausea disappeared as soon as I began the rectal administration of Ergotamine. I have not yet observed a habituation effect or addictive behaviour with a tendency to increase the dosage or to apply it more frequently.